PMID: 9438407Jan 23, 1998Paper

Peripheral markers in testing pathophysiological hypotheses and diagnosing Alzheimer's disease

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
L GaspariniStefano Govoni

Abstract

Alterations in amyloid precursor protein (APP) metabolism, calcium regulation, oxidative metabolism, and transduction systems have been implicated in Alzheimer's disease (AD). Limitations to the use of postmortem brain for examining molecular mechanisms underscore the need to develop a human tissue model representative of the pathophysiological processes that characterize AD. The use of peripheral tissues, particularly of cultured skin fibroblasts derived from AD patients, could complement studies of autopsy samples and provide a useful tool with which to investigate such dynamic processes as signal transduction systems, ionic homeostasis, oxidative metabolism, and APP processing. Peripheral cells as well as body fluids (i.e., plasma and CSF) could also provide peripheral biological markers for the diagnosis of AD. The criteria required for a definite diagnosis of AD presently include clinical criteria in association with histopathologic evidence obtained from biopsy or autopsy. Thus, the use of peripheral markers as a diagnostic tool, either to predict or at least to confirm a diagnosis, may be of great importance.

References

Dec 31, 1992·Annals of the New York Academy of Sciences·W E Van NostrandS L Wagner
Jan 1, 1992·Journal of Neural Transmission. Parkinson's Disease and Dementia Section·P HartikainenP J Riekkinen
May 1, 1992·Journal of Affective Disorders·C M BankiC B Nemeroff
Jan 1, 1992·Neurobiology of Aging·D R MarshakW S Griffin
May 1, 1992·Neuroreport·M M Strittmatter, H Cramer
Sep 30, 1992·Biochemical and Biophysical Research Communications·S L GillespieS G Younkin
Apr 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·W E Van NostrandC W Cotman
Apr 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·G L CaporasoP Greengard
Mar 15, 1992·Mechanisms of Ageing and Development·G E Gibson, L Toral-Barza
Jul 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·S S Sisodia
Jan 1, 1991·The Journal of Steroid Biochemistry and Molecular Biology·J M ReulE R de Kloet
Jan 1, 1991·European Neurology·C WikkelsöB Johansson
Jun 1, 1991·Journal of Neurology·A MolinsR Galard
Jan 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·M J AdlerN N Dewji
Mar 1, 1991·Mutation Research·G CarmelietJ J Cassiman
Nov 25, 1991·Neuroscience Letters·A BruelJ Delabar
May 1, 1991·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·A WallinE Widerlöv
Aug 1, 1991·Journal of Neuroimmunology·A AdunskyY A Mekori
Mar 15, 1991·Biochemical and Biophysical Research Communications·A Matsumoto, Y Fujiwara
Jan 1, 1990·Journal of Neural Transmission. Supplementum·L MinthonL Gustafson
Sep 1, 1990·Metabolism: Clinical and Experimental·M F Beal
Dec 1, 1990·Journal of Neuroscience Research·K J ReinikainenP J Riekkinen
Aug 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·J D BuxbaumP Greengard
Mar 31, 1990·Mechanisms of Ageing and Development·G CarmelietJ J Cassiman
Aug 1, 1990·Neurology·W D ParkerJ K Parks
Oct 1, 1990·Acta Psychiatrica Scandinavica·A TakaiH Ueki
Feb 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·M J IgnatiusE M Shooter

❮ Previous
Next ❯

Citations

Aug 22, 2006·Proceedings of the National Academy of Sciences of the United States of America·Tapan K Khan, Daniel L Alkon
May 1, 2009·Expert Review of Neurotherapeutics·Masahiro KawaharaYutaka Sadakane
Oct 18, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Yuh-Jiin I JongNancy Lewis Baenziger
Mar 3, 2004·American Journal of Medical Genetics. Part a·Edmund C JenkinsWayne P Silverman
Jan 5, 2011·International Journal of Alzheimer's Disease·Enrico MosselloNiccolò Marchionni
Jun 1, 2012·Molecular Neurobiology·M T GentileL Colucci-D'Amato
Oct 6, 2012·Biological & Pharmaceutical Bulletin·Satoko UchidaShigeharu Fukuda
Feb 22, 2012·Molecular Neurobiology·Georg AuburgerMarina Jendrach
Feb 3, 2015·Electrophoresis·Raúl González-DomínguezJosé Luis Gómez-Ariza
Jul 10, 2001·Aging : Clinical and Experimental Research·A Bianchetti, M Trabucch
Apr 27, 2002·Annals of the New York Academy of Sciences·Denham Harman
Jul 5, 2003·Bioscience, Biotechnology, and Biochemistry·Ho-Jin HeoDong-Hoon Shin
Sep 25, 2004·Bioscience, Biotechnology, and Biochemistry·Hye Kyung KimJoo Ho Chung
Jun 28, 2002·Physiological Reviews·Mark P MattsonWenzhen Duan
Aug 18, 2006·Neurochemical Research·Vincenzo GiordanoMenotti Calvani
Jul 1, 2000·Journal of the American Aging Association·D Harman
Jan 27, 2012·Nature·Mason A IsraelLawrence S B Goldstein
Sep 3, 2010·Experimental Dermatology·Stephan SchremlPhilipp Babilas
Aug 15, 2014·Journal of Medicinal Food·Mi-Ran ChoiEun Ji Kim
Apr 27, 2000·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·D C SolanoM Racchi
Jun 21, 2014·International Journal of Alzheimer's Disease·Alessandra MocaliFrancesco Paoletti
May 7, 2011·International Journal of Alzheimer's Disease·Masahiro KawaharaYutaka Sadakane
Feb 22, 2012·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·S WangJ Jia
Aug 21, 2004·The Journal of Biological Chemistry·Maria Teresa GentileGiuseppe Lembo
Oct 20, 2018·Molecular Neurobiology·Athanasios AlexiouGhulam Md Ashraf
Feb 27, 2001·Cell Biochemistry and Function·F BrahimiG Siest
Mar 30, 2001·The Journal of Biological Chemistry·A D TagalakisJ S Owen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Calcium & Bioenergetics

Bioenergetic processes, including cellular respiration and photosynthesis, concern the transformation of energy by cells. Here is the latest research on the role of calcium in bioenergetics.